肺移植中的FK506挽救治疗。 - Suppr | 超能文献

FK506 rescue therapy in lung transplantation.

作者信息

Wiebe K, Harringer W, Franke U, Strüber M, Krug N, Korff F, Wahlers T, Cremer J, Haverich A

机构信息

Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany.

出版信息

Transplant Proc. 1998 Jun;30(4):1508-9. doi: 10.1016/s0041-1345(98)00336-4.

DOI:10.1016/s0041-1345(98)00336-4

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

FK506 rescue therapy in lung transplantation.肺移植中的FK506挽救治疗。

Transplant Proc. 1998 Jun;30(4):1508-9. doi: 10.1016/s0041-1345(98)00336-4.

2

Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.他克莫司在患有囊性纤维化的心肺联合移植和双肺移植受者中的临床应用及生物利用度。

Transplant Proc. 1998 Jun;30(4):1519-20. doi: 10.1016/s0041-1345(98)00341-8.

3

Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.

Transplantation. 2000 Aug 15;70(3):522-5. doi: 10.1097/00007890-200008150-00021.

4

Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.雷帕霉素对体外生长因子刺激的成人肺成纤维细胞的抗增殖作用，可能解释了其在体内预防和治疗同种异体移植闭塞性气道疾病方面的卓越疗效。

Transplant Proc. 1997 Feb-Mar;29(1-2):614-5. doi: 10.1016/s0041-1345(96)00325-9.

5

FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.FK506对心肺移植受者不可逆气道排斥反应的挽救治疗：5例报告

Transplant Proc. 1994 Dec;26(6):3240-1.

6

Pulmonary rejection diagnosis after lung and heart-lung transplantation.肺移植和心肺移植后的肺排斥反应诊断

Transplant Proc. 1993 Dec;25(6):3299-300.

7

International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.环孢素转换为他克莫司用于急性和慢性肺移植排斥反应的国际经验。

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1126-32. doi: 10.1016/j.jtcvs.2003.11.009.

8

Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation.在肺移植后闭塞性细支气管炎的管理中，通过他克莫司/环孢素转换来保护小气道功能。

J Heart Lung Transplant. 2000 Dec;19(12):1219-23. doi: 10.1016/s1053-2498(00)00206-0.

9

Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.他克莫司（FK506）在治疗胸内移植后持续性排斥反应发作方面比OKT3更具优势。

Transplant Proc. 1997 Feb-Mar;29(1-2):605-6. doi: 10.1016/s0041-1345(96)00321-1.

10

Tacrolimus-based immunosuppressive protocols in lung transplantation.肺移植中基于他克莫司的免疫抑制方案

Transplant Proc. 1999 Feb-Mar;31(1-2):171-2. doi: 10.1016/s0041-1345(98)01488-2.

引用本文的文献

1

Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.监测肺疾病和肺移植受者的非甾体免疫抑制剂：美国胸科医师学会循证临床实践指南。

Chest. 2012 Nov;142(5):e1S-e111S. doi: 10.1378/chest.12-1044.

2

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新

Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.